OFFICIAL PUBLICATION OF

by its subsidiary APPco

Ellura recall

Megan Haggan 14/02/2022

A batch of Ellura capsules has been recalled due to the presence of ethylene oxide The TGA has announced that in consultation with SFI Australasia, it has initiated a recall for one batch of the capsules, used to support urinary tract health. The affected batch is N0121301 (expiry 01/2024). It was first sold into the

This content is restricted to registered users only. If you have already registered on the AJP website please login below, Or you can Register for free.

Recent Comments
Popular Posts

ACCC announces Chemist Warehouse/Sigma merger decision

I didn't realise there was a reply deadline here? Feel free to take your time and respond when you can…

John Smith

Counterfeit ivermectin

I disagree with you Leo, the TGA is our national regulator of medicines and medical devices and they do have…

Brad Sparling

Sigma/CWH merger to change pharmacy

Yeh their entire business model is to put Priceline in their shopping centres paying 3-4x the amount of rent a…

Bob Tran

Sigma/CWH merger to change pharmacy

The problem Wesfarmers have is that their control over individual Pricelines is too small compared to CWH. Any greater control…

Paul Sapardanis

Ellura recall

Previous Not being average

Next Three lives per day saved

In the beginning

The signs of ageing

Hyperpigmentation

How to avoid dry skin

MENU

Previous Not being average

Next Three lives per day saved

Related Posts

MENU

Hi there! 👋 Looks like you’re not logged in.